Showing 2931-2940 of 3223 results for "".
- FDA Authorizes Hand-Held COVID-19 Diagnostic Testhttps://modernod.com/news/fda-authorizes-hand-held-covid-19-diagnostic-test/2477452/In response to the coronavirus crisis, we’ve seen COVID-19 diagnostics quickly evolve from early, multistep kits to high-throughput versions to fast point-of-care tests, all in just a few weeks. Now, the FDA has granted an emergency authorization to a device that fits in the palm of you
- ImprimisRx to Provide Healthcare Professionals With Telemedicine Serviceshttps://modernod.com/news/imprimisrx-to-provide-healthcare-professionals-with-telemedicine-services/2477446/ImprimisRx, a wholly-owned subsidiary of Harrow Health, announced that they have entered into an exclusive agreement with Doxy.me, a full-service telemedicine solution. The agreement will provide all ImprimisRx ophthalmology, optometry, and wellness practices with the Clinic level
- Arnold & Porter to Host Webinar on Proposed CARES Acthttps://modernod.com/news/arnold-porter-to-host-webinar-on-proposed-cares-act/2477437/The coronavirus has swept across the United States, paralyzing much of the nation, ending a record run on Wall Street, and inducing a level of economic uncertainty and anxiety that threatens to plunge us all into a global recession or depression. The resulting crisis has created unprecedented eme
- President of Glaucoma Research Foundation Issues Messagehttps://modernod.com/news/president-of-glaucoma-research-foundation-issues-message/2477429/The Glaucoma Research Foundation sent an email to its membership on Friday, answering questions that glaucoma specialists may have during the COVID-19 pandemic. The letter reads: Dear Friends, Your health and well-being are on our minds as we all deal with a national and glob
- A Majority of ECPs Reduce Office Hours, Expect Lower Revenues as COVID-19 Situation Expands, Survey Findshttps://modernod.com/news/a-majority-of-ecps-reduce-office-hours-expect-lower-revenues-as-covid-19-situation-expands-jobson-research-survey-finds/2477428/Almost four in five eyecare professionals (primarily independent optometrists and opticians) have taken steps, or are considering, a move to reduce office hours, and about four in 10 are considering temporarily closing their offices in response to the coronavirus outbreak, according to a
- Bayer Partners With U.S. Government on Major Product Donation to Fight Coronavirushttps://modernod.com/news/bayer-partners-with-u-s-government-on-major-product-donation-to-fight-coronavirus/2477417/Bayer announced it is joining the U.S. Government’s fight against COVID-19 with a donation of 3 million tablets of the drug Resochin (chloroquine phosphate). Resochin, a product discovered by Bayer in 1934 and indicated for prevention and treatment of malaria, also appears to have br
- State Department to Tell Americans Don’t Travel Abroad, Come Home If Overseashttps://modernod.com/news/state-department-to-tell-americans-dont-travel-abroad-come-home-if-overseas/2477418/The State Department is set to announce a Level 4 travel advisory applying to all international travel, its most severe warning, three individuals with knowledge of the pending announcement said, according to a Politico
- President Invokes the Defense Production Act in Response to COVID-19https://modernod.com/news/president-invokes-the-defense-production-act-in-response-to-covid-19/2477413/The President and the Secretary of Health and Human Services (HHS) reportedly plan to invoke the Defense Production Act of 1950 (DPA) to support the COVID-19 response by giving the federal government priority over all other customers for items such as masks and ventilators, according to an Arnold
- CMS Recommends Limit on Nonessential Planned Surgeries, Including Postponement of Cataract Procedureshttps://modernod.com/news/cms-recommends-limit-on-nonessential-planned-surgeries-including-postponement-of-cataract-procedures/2477414/On March 18, CMS issued a series of recommendations regarding the furnishing of all nonessential planned surgeries and procedures based on the need to conserve critical resources, such as ventilators and personal protective equipment, and limiting exposure of patients and staff to COVID-19, accor
- Regeneron’s Novel COVID-19 Antibody Program Has Potential to Enter Human Clinical Studies by Early Summerhttps://modernod.com/news/regenerons-novel-covid-19-antibody-program-has-potential-to-enter-human-clinical-studies-by-early-summer/2477404/Regeneron Pharmaceuticals announced the latest progress in its efforts to discover and develop a novel multi-antibody cocktail that can be administered as prophylaxis before exposure to the SARS-CoV-2 virus or as treatment for those already infected. Regeneron scientists have now isolated